Keywords
pulmonary disease, chronic obstructive
The Chronic Respiratory Disease Questionnaire: CRQ
How to Cite
Abstract
Chronic Obstructive Pulmonary Disease (COPD) is characterized by chronic airflow limitation with pulmonary pathological changes and significant extrapulmonary changes causing important changes in the quality of life of those who suffer from it. Objective: to describe the health-related quality of life in COPD patients who attend a consultation in a primary care center in the city of Pereira, Colombia. Materials and method: A descriptive cross-sectional study was carried out that included 43 patients who are ≥ 40 years old and a confirmed diagnosis of COPD, who attended a consultation in a primary care center between June-December 2019, and met inclusion criteria; quality of life related to health was evaluated using the Chronic Respiratory Disease Questionnaire (CRQ). Results: sociodemographic characterization of the patients reported average ages 67.8 ± 7.8 years, and the predominant gender was male with 67.4%. The total score of the questionnaire on health-related quality of life had a median for the study group of 4.9 (Irq, ± 1.1). Dyspnea was the dimension with the lowest score, compared to the other dimensions of the questionnaire. Conclusion: Dyspnea is the main symptom with the greatest impact on the activities of daily life of patients and induces the sensation of fatigue and aggravates the perception of the impact of the disease in their lives.
References
Health USN, Sur- NE. 2000_Copd. 2000;269-80.
Rossi A, Butorac-Petanjek B, Chilosi M, Cosío BG, Flezar M, Koulouris N, et al. Chronic obstructive pulmonary disease with mild airflow limitation: Current knowledge and proposal for future research – A consensus document from six scientific societies. Int J COPD. 2017;12:2593-610.
Mann R, Nichols J. Management of Chronic Obstructive Pulmonary Disease. Am J Lifestyle Med. 2009;3(6):458-65.
Cooper CB. Assessment of pulmonary function in COPD. Semin Respir Crit Care Med. 2005;26(2):246-52.
Eisner MD, Trupin L, Katz PP, Yelin EH, Earnest G, Balmes J, et al. Development and validation of a survey-based COPD severity score. Chest [Internet]. 2005;127(6):1890-7. Disponible en: http://dx.doi.org/10.1378/chest.127.6.1890
Celli BR, Decramer M, Wedzicha JA, Wilson KC, Agustí A, Criner GJ, et al. An Official American Thoracic Society/European Respiratory Society Statement: Research questions in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2015;191(7):e4-27.
Miravitlles M, Soler-Cataluña JJ, Calle M, Molina J, Almagro P, Quintano JA, et al. Spanish Guidelines for Management of Chronic Obstructive Pulmonary Disease (GesEPOC) 2017. Pharmacological Treatment of Stable Phase. Arch Bronconeumol. 2017;53(6):324-35.
Luna JM, Jardim JR, López H, Luna CM, Mazzei JA, Stamboulian D, et al. Actualización de las recomendaciones ALAT sobre la exacerbación infecciosa de la EPOC. Arch Bronconeumol. 2004;40(7):315-25.
Pauwels R, Buist S, Calverley P, Jenkins C, Hurd S. Global strategy for the diagnosis, management and prevention of Chronic Obstructive Pulmonary Disease. NHBLI/WHO global initiative for Chronic Obstructive Lung Disease (GOLD) workshop summary. Rev Port Pneumol. 2001;7(4-5):398-400.
Qaseem A, Wilt TJ, Weinberger SE, Hanania NA, Criner G, van der Molen T, et al. Disease: A clinical practice guideline update from the american college of physicians, american college of chest physicians, american thoracic society, and european respiratory society. Ann Intern Med. 2011;155(3):179-91.
Montes M et. al. Recomendaciones para el Diagnostico y Tratamiento de la Enfermedad Pulmonar Obstructiva Cronica. Asoc Latinoam Torax. 2011;1(1):1-43.
Cano-rosales DJ, Bolívar-grimaldos F. Health-related quality of life in patients with chronic obstructive pulmonary disease in Hospital Universitario de Santander. 5. Disponible en: http://www.scielo.org.co/pdf/muis/v30n2/0121-0319-muis-30-02-00011.pdf
Caballero A, Torres-Duque CA, Jaramillo C, Bolívar F, Sanabria F, Osorio P, et al. Prevalence of COPD in five Colombian cities situated at low, medium, and high altitude (PREPOCOL study). Chest. 2008;133(2):343-9.
Estrada Álvarez JM, Ossa García X, del Quijano del Gordo CI, Bustos L, Urina DP, Pérez CF, et al. Validation of the chronic respiratory questionnaire in the Colombian population with chronic obstructive pulmonary disease. Qual Life Res. 2015;24(8):2039-44.
Serón S P, Riedemann G P, Sanhueza A, Doussoulin S A, Villarroel A P. Validación del Cuestionario de la enfermedad respiratoria crónica en pacientes chilenos con limitación crónica del flujo aéreo. Rev Med Chil. 2003;131(11):1243-50.
GOLD. The Global Initiative for Chronic Obstructive Lung Disease (2019). Global Strategy for the Diagnosis, Management and Prevention of COPD. Retrieved from. Gold. 2019;
Estrada-Álvarez JM, Orozco-Hernández JP, Aristizábal-Franco LE. Validación del puntaje de valoración de la gravedad de la enfermedad pulmonar obstructiva crónica en población colombiana en un servicio de atención primaria. Biomédica. 2020;40(4):664-72.
Scichilone N, Marchese R, Catalano F, Vignola AM, Togias A, Bellia V. Bronchodilatory effect of deep inspiration is absent in subjects with mild COPD. Chest [Internet]. 2004;125(6):2029-35. Disponible en: http://dx.doi.org/10.1378/chest.125.6.2029
Herrera-García JC, Montiel Castro JS, Caballero-López CG, Arellano-Montellano EI, Jaramillo-Arellano LE, Arellano AE. Eosinophilia prevalence and clinical characteristics in a cohort of patients with chronic obstructive pulmonary disease in a third-level hospital in Puebla. Med Interna Mex. 2018;34(5):692-6.
Cherian M, Jensen D, Tan WC, Mursleen S, Goodall EC, Nadeau GA, et al. Dyspnoea and symptom burden in mild–moderate COPD: the Canadian Cohort Obstructive Lung Disease Study. ERJ Open Res [Internet]. 2021;7(2):00960-2020. Disponible en: http://dx.doi.org/10.1183/23120541.00960-2020
Nonato NL, Díaz O, Nascimento OA, Dreyse J, Jardim JR, Lisboa C. Comportamiento de la calidad de vida (SGRQ) en pacientes con EPOC según las puntuaciones BODE. Arch Bronconeumol. 2015;51(7):315-21.
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
Copyright (c) 2021 Darys Luz Osuna-Julio, Jorge Mario Estrada-Álvarez, María Camila Araya-Marín, Leslie Alexandra Meléndez-Puchana, Angela Liceth P´érez-Rendón